Seth M. Pollack

4.9k total citations
120 papers, 2.2k citations indexed

About

Seth M. Pollack is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Seth M. Pollack has authored 120 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Oncology, 70 papers in Pulmonary and Respiratory Medicine and 39 papers in Immunology. Recurrent topics in Seth M. Pollack's work include Sarcoma Diagnosis and Treatment (64 papers), CAR-T cell therapy research (41 papers) and Immunotherapy and Immune Responses (33 papers). Seth M. Pollack is often cited by papers focused on Sarcoma Diagnosis and Treatment (64 papers), CAR-T cell therapy research (41 papers) and Immunotherapy and Immune Responses (33 papers). Seth M. Pollack collaborates with scholars based in United States, United Kingdom and Canada. Seth M. Pollack's co-authors include Robin L. Jones, Elizabeth T. Loggers, Eve T. Rodler, Lee D. Cranmer, Cassian Yee, Venu G. Pillarisetty, Michael J. Wagner, Emanuela Palmerini, Paul H. Huang and Robert H. Pierce and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Seth M. Pollack

111 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth M. Pollack United States 27 1.3k 1.1k 651 358 264 120 2.2k
Sophie Le Guellec France 26 997 0.8× 928 0.8× 564 0.9× 375 1.0× 188 0.7× 59 2.1k
Brian Andrew Van Tine United States 22 1.6k 1.3× 1.7k 1.5× 371 0.6× 461 1.3× 473 1.8× 121 2.7k
Neeta Somaiah United States 30 1.4k 1.1× 1.7k 1.6× 383 0.6× 793 2.2× 520 2.0× 169 2.9k
Breelyn A. Wilky United States 22 912 0.7× 977 0.9× 243 0.4× 379 1.1× 280 1.1× 101 1.7k
Tianhua Guo United States 14 921 0.7× 1.6k 1.4× 340 0.5× 336 0.9× 265 1.0× 14 2.8k
Isidro Machado Spain 27 741 0.6× 1.3k 1.2× 156 0.2× 646 1.8× 286 1.1× 126 2.2k
François Le Loarer France 26 1.4k 1.1× 1.7k 1.5× 246 0.4× 792 2.2× 404 1.5× 117 3.0k
Íñigo Espinosa Spain 27 919 0.7× 865 0.8× 577 0.9× 976 2.7× 70 0.3× 56 2.9k
Mitsunori Kaya Japan 27 818 0.6× 863 0.8× 240 0.4× 1.0k 2.8× 148 0.6× 71 2.5k
Lorenzo D’Ambrosio Italy 18 590 0.5× 777 0.7× 151 0.2× 337 0.9× 132 0.5× 50 1.2k

Countries citing papers authored by Seth M. Pollack

Since Specialization
Citations

This map shows the geographic impact of Seth M. Pollack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth M. Pollack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth M. Pollack more than expected).

Fields of papers citing papers by Seth M. Pollack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth M. Pollack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth M. Pollack. The network helps show where Seth M. Pollack may publish in the future.

Co-authorship network of co-authors of Seth M. Pollack

This figure shows the co-authorship network connecting the top 25 collaborators of Seth M. Pollack. A scholar is included among the top collaborators of Seth M. Pollack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth M. Pollack. Seth M. Pollack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benabdallah, Nezha S., Li Li, Jinxiu Li, et al.. (2025). DNA demethylating agents suppress preclinical models of synovial sarcoma. Journal of Clinical Investigation. 135(13). 1 indexed citations
2.
3.
Wu, Hao, Madina Sukhanova, Haiming Tang, et al.. (2024). Use of Mitotic Activity and the Size of Any Dedifferentiated Component for Risk Assessment in MDM 2-Amplified Liposarcoma. Archives of Pathology & Laboratory Medicine. 149(5). 422–430. 1 indexed citations
4.
Pandey, Surya, Jeffrey A. Sosman, Marie‐Pier Tétreault, et al.. (2024). Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond. Cancers. 16(3). 475–475. 1 indexed citations
5.
Alexiev, Borislav A., Eleanor Y. Chen, Brett Schroeder, et al.. (2024). B7-H3 is widely expressed in soft tissue sarcomas. BMC Cancer. 24(1). 1336–1336. 2 indexed citations
6.
Cranmer, Lee D., Karla V. Ballman, Elizabeth T. Loggers, et al.. (2023). Bolus versus Continuous Intravenous Delivery of Doxorubicin in Soft-Tissue Sarcomas: Post Hoc Analysis of a Prospective Randomized Trial (SARC021/TH CR-406). Clinical Cancer Research. 29(6). 1068–1076. 1 indexed citations
7.
Liang, Jiyong, Dexing Fang, Joy Gumin, et al.. (2023). A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin. Cancers. 15(4). 1085–1085. 1 indexed citations
8.
Pollack, Seth M., et al.. (2023). Pushing forward in sarcoma with a new TCR targeting NY-ESO-1. Cell Reports Medicine. 4(8). 101159–101159. 3 indexed citations
9.
Schroeder, Brett, Bonnie LaFleur, Rachel Gittelman, et al.. (2021). CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes. Journal for ImmunoTherapy of Cancer. 9(8). e002812–e002812. 25 indexed citations
10.
Somaiah, Neeta, Matthew S. Block, Joseph W. Kim, et al.. (2019). First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1. Clinical Cancer Research. 25(19). 5808–5817. 71 indexed citations
11.
Seo, Yongwoo David, Xiuyun Jiang, Kevin M. Sullivan, et al.. (2019). Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer. Clinical Cancer Research. 25(13). 3934–3945. 170 indexed citations
12.
Kohli, Karan, Yao Lu, Qianchuan He, et al.. (2019). Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial. Cancer Immunology Research. 7(8). 1237–1243. 101 indexed citations
13.
Spraker, Matthew B., Landon S. Wootton, Daniel S. Hippe, et al.. (2019). MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue Sarcoma. Advances in Radiation Oncology. 4(2). 413–421. 54 indexed citations
14.
Pollack, Seth M., et al.. (2017). Phase III Soft Tissue Sarcoma Trials: Success or Failure?. Current Treatment Options in Oncology. 18(3). 19–19. 15 indexed citations
15.
Jones, Robin L., Daniela Katz, Elizabeth T. Loggers, et al.. (2017). Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma. Medical Oncology. 34(10). 167–167. 33 indexed citations
16.
Monroe, Eric J., Guy E. Johnson, Elizabeth T. Loggers, et al.. (2016). Promising efficacy with liver-directed therapies for the treatment of metastatic and unresectable hepatic sarcomas. Journal of Vascular and Interventional Radiology. 27(3). S173–S173. 1 indexed citations
17.
Palmerini, Emanuela, Robin L. Jones, Emanuela Marchesi, et al.. (2016). Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone. BMC Cancer. 16(1). 280–280. 72 indexed citations
18.
Pollack, Seth M., Achim A. Jungbluth, Benjamin Hoch, et al.. (2012). NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma. Cancer. 118(18). 4564–4570. 101 indexed citations
19.
Pollack, Seth M., Elizabeth T. Loggers, Eve T. Rodler, Cassian Yee, & Robin L. Jones. (2011). Immune-Based Therapies for Sarcoma. Sarcoma. 2011. 1–7. 26 indexed citations
20.
Pollack, Seth M., T O'Connor, Jana G. Hashash, & Imad A. Tabbara. (2009). Nonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation. American Journal of Clinical Oncology. 32(6). 618–628. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Le Guellec Breakdown of academic impact, for papers by Brian Andrew Van Tine Breakdown of academic impact, for papers by Neeta Somaiah Breakdown of academic impact, for papers by Breelyn A. Wilky Breakdown of academic impact, for papers by Tianhua Guo Breakdown of academic impact, for papers by Isidro Machado Breakdown of academic impact, for papers by François Le Loarer Breakdown of academic impact, for papers by Íñigo Espinosa Breakdown of academic impact, for papers by Mitsunori Kaya Breakdown of academic impact, for papers by Lorenzo D’Ambrosio
Rankless by CCL
2026